LINDSEY CORBETT: Open Payments
NPI 1154921641 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 7 payments from 6 companies in 2025. Trend: 2023 $482 · 2024 $180 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $153 |
| NxStage Medical, Inc. | 1 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: TARPEYO, NXSTAGE SYSTEM ONE, JARDIANCE, REXULTI, FARXIGA, Vanrafia.
Industry payments across NC — which companies pay providers there.
